NCT02980458View on ClinicalTrials.gov

Characterisation of Relative Bioavailability With Bioequivalence Assessment of Deferiprone Tablets After Oral Single Dose Administration

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions

Bioequivalence

Interventions

DRUG

Deferiprone 500Mg Tablet

DRUG

Deferiprone 500 MG Oral Tablet [Ferriprox]

Trial Locations (1)

99084

SocraTec R&D GmbH Clinical Pharmacology Unit, Erfurt

All Listed Sponsors

collaborator

SocraMetrics GmbH

INDUSTRY

lead

SocraTec R&D GmbH

OTHER

NCT02980458 - Characterisation of Relative Bioavailability With Bioequivalence Assessment of Deferiprone Tablets After Oral Single Dose Administration | Biotech Hunter | Biotech Hunter